The size of the Sterile Filtration Market in Europe was valued at USD 1.66 billion in 2022. It is estimated to be growing at a CAGR of 11.96% to reach USD 2.92 billion by 2027.
Awareness concerning filtration tools is increasing in Europe, which is predicted to reflect the growth of the sterile filtration market in this region. The purchasing power to buy expensive filtration equipment and accessories is very high for Europe and drives the market. The monitoring mandates for cleanrooms in pharmaceutical manufacturing is also expected to accelerate the market. The growing stipulation for sterile filtration of drugs in this region may reflect the growth of the market.
The shortage of skilled workforce is a significant restraint to market growth. Stringent government rules and regulations for the filtration procedures are a significant challenge to the companies operating in the market. Similarly, the sterile filtration process's high cost may hinder the growth of the market in the upcoming years.
This research report on the Europe Sterile Filtration Market has been segmented and sub-segmented into the following categories:
The European sterile filtration market accounted for a share of 28.2% in the global market in 2019, and the trend of occupying leading shares is expected to continue throughout the forecast period. Factors such as growing R&D, the increasing requirement for biopharmaceutical molecules, and escalating purity stipulation among the end-users are predicted to drive the market expansion.
The UK is expected to dominate the sterile filtration market in this region due to the developments in the technology of Nanofibers, increasing production of giant molecules and biologics, and grow within the generics market. Rising funds and investments for research and development activities and mounting pharmaceutical and biopharmaceutical industries surge the sterile filtration market growth during the estimation period. In the UK, the occurrence rate of chronic and acute diseases is high, which is projected to accelerate the development of the sterile filtration market. Besides this, the rising occurrence rate of diabetes and kidney failure, endorsement of the latest technologies, and novel, innovative products for end-users are to bolster the market growth. The rising selection of single-use technologies, having deep attention to enhancing immense biopharmaceutical drugs in sterile filtration, growing obesity is augmenting the market expansion. Germany, France are expected to have considerable growth in the foreseen years in the region.
The most promising companies leading the Europe Sterile filtration market include Merck & Co., Inc., 3M, General Electric Company, Pall Corporation, Parker Hannifin Corporation, Sartorius Stedim Biotech Group, Porvair Filtration Group, Sterlitech Corporation, and Starlab Scientific Co., Ltd
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org